Evaluation of the cervicovaginal environment in asymptomatic Human T-cell lymphotropic virus type 1 infected women.
Adult
Body Fluids
/ chemistry
Cervix Uteri
/ immunology
Cross-Sectional Studies
Cytokines
/ analysis
Enzyme-Linked Immunosorbent Assay
Female
HTLV-I Infections
/ immunology
Human T-lymphotropic virus 1
/ isolation & purification
Humans
Interleukin-17
/ immunology
Leukocytes, Mononuclear
/ virology
Social Class
Statistics, Nonparametric
Th1 Cells
/ immunology
Th2 Cells
/ immunology
Vagina
/ immunology
Viral Load
Cervicovaginal cytopathology
HTLV-1
Inflammatory cytokines
Proviral load
Journal
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
ISSN: 1678-4391
Titre abrégé: Braz J Infect Dis
Pays: Brazil
ID NLM: 9812937
Informations de publication
Date de publication:
Historique:
received:
14
09
2018
revised:
29
01
2019
accepted:
07
02
2019
pubmed:
9
3
2019
medline:
30
5
2019
entrez:
9
3
2019
Statut:
ppublish
Résumé
Human T-cell lymphotropic virus type 1 (HTLV-1) is sexually transmitted and causes persistent infection. This virus induces activation of the immune system and production of inflammatory cytokines. This study aimed to assess the cytokine profile and cytopathological findings in the cervicovaginal fluid of asymptomatic HTLV-1-infected women. HTLV-1-infected and uninfected women were selected at the Centro de Atendimento ao Portador de HTLV in Salvador-Brazil. None of the included HTLV-1-infected women reported any HTLV-1-associated diseases. All volunteers underwent gynecological examination to collect cervicovaginal fluid. Cytokine quantification was performed using the Cytometric Bead Array (CBA) Human Th1/Th2/Th17 kit. Light microscopy was used to evaluate cervicovaginal cytopathology. In addition, proviral load in cervicovaginal fluid and peripheral blood was measured by real-time quantitative polymerase chain reaction. 112 women (63 HTLV-1-infected and 49 uninfected) were evaluated. No differences were found with respect to cytopathological cervicovaginal findings between the groups. IL-2, TNF, IL-4, IL-10, and IL-17 levels were significantly higher in cervicovaginal fluid of the HTLV-1-infected women than in uninfected women (p<0.05). Conversely, IFN-γ was found to be lower in the HTLV-1-infected women (p<0.001) compared to uninfected individuals. Cervicovaginal proviral load was detectable in 53% of the HTLV-1-infected women and was found to be consistently lower than the proviral load in peripheral blood. HTLV-1 infection induces immune activation in cervicovaginal environment, characterized by elevated concentrations of Th1, Th2, and IL17 in the cervicovaginal fluid.
Identifiants
pubmed: 30849331
pii: S1413-8670(18)30605-6
doi: 10.1016/j.bjid.2019.02.001
pmc: PMC9428004
pii:
doi:
Substances chimiques
Cytokines
0
Interleukin-17
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
27-33Informations de copyright
Copyright © 2019 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U. All rights reserved.
Références
Eur J Obstet Gynecol Reprod Biol. 2008 May;138(1):93-9
pubmed: 17683845
PLoS Negl Trop Dis. 2013 Oct 10;7(10):e2479
pubmed: 24130912
J Infect Dis. 2000 Mar;181(3):939-45
pubmed: 10720516
J Med Virol. 2012 Nov;84(11):1809-17
pubmed: 22997085
Lancet. 1985 Aug 24;2(8452):407-10
pubmed: 2863442
J Infect Dis. 1992 Oct;166(4):943-4
pubmed: 1527436
PLoS One. 2017 Feb 3;12(2):e0171303
pubmed: 28158226
J Clin Virol. 2011 Nov;52(3):177-80
pubmed: 21868282
J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):527-31
pubmed: 14657765
Rheumatol Int. 2010 Apr;30(6):775-8
pubmed: 19639323
Clin Exp Immunol. 2009 Jun;156(3):455-62
pubmed: 19438598
J Acquir Immune Defic Syndr. 2001 May 1;27(1):1-6
pubmed: 11404513
J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S46-9
pubmed: 8797703
J Infect Dis. 2002 Dec 1;186(11):1669-72
pubmed: 12447745
Rev Assoc Med Bras (1992). 2010 May-Jun;56(3):370-4
pubmed: 20676549
J Exp Med. 1989 Dec 1;170(6):2081-95
pubmed: 2531194
Arthritis Rheum. 1996 Aug;39(8):1410-8
pubmed: 8702452
Front Microbiol. 2012 Nov 15;3:388
pubmed: 23162541
Sex Transm Infect. 2004 Apr;80(2):108-12
pubmed: 15054170
Cytokine. 1995 Aug;7(6):568-74
pubmed: 8580374
J Med Virol. 2016 Aug;88(8):1438-47
pubmed: 26800845
BMC Infect Dis. 2014 Aug 22;14:453
pubmed: 25148903
J Med Virol. 2011 Jul;83(7):1269-74
pubmed: 21567429
Acta Trop. 2013 Jan;125(1):75-81
pubmed: 23022356
BMC Infect Dis. 2015 Jul 06;15:258
pubmed: 26143070
J Immunol Res. 2016;2016:8402059
pubmed: 26904697
J Med Virol. 1996 Sep;50(1):42-9
pubmed: 8890040
Inflamm Allergy Drug Targets. 2008 Jun;7(2):98-107
pubmed: 18691139
AIDS Res Hum Retroviruses. 1992 Sep;8(9):1699-706
pubmed: 1457215
J Virol Methods. 2002 Apr;102(1-2):37-51
pubmed: 11879691
Immunology. 2015 Dec;146(4):557-67
pubmed: 26302175
J Virol. 1990 Nov;64(11):5682-7
pubmed: 1976827
JAMA. 2002 Apr 24;287(16):2114-9
pubmed: 11966386
Acta Cytol. 2016;60(1):58-64
pubmed: 27003414
Proc Natl Acad Sci U S A. 1983 Sep;80(17):5402-6
pubmed: 6604273
Proc Natl Acad Sci U S A. 1982 Mar;79(6):2031-5
pubmed: 6979048